Screener
Zevra Therapeutics, Inc. ZVRA Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
FAQ
- What is Zevra Therapeutics, Inc.'s inventories?
- Zevra Therapeutics, Inc. (ZVRA) reported inventories of $0 in Q2 2026.
- How has Zevra Therapeutics, Inc.'s inventories changed year-over-year?
- Zevra Therapeutics, Inc.'s inventories decreased by 100.0% year-over-year, from $782K to $0.
- What is the long-term trend for Zevra Therapeutics, Inc.'s inventories?
- Over 3 years (2022 to 2025), Zevra Therapeutics, Inc.'s inventories has grown at a 85.2% compound annual growth rate (CAGR), from $2.05M to $13M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about Zevra Therapeutics, Inc.'s inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude